COMMENT

IVD companies seek M&As to avoid Covid cliff

The CGM-led diabetes market revolution post-Covid-19 outbreak

AstraZeneca's quick AZD1222 vaccine trial restart splits opinion among experts

outlook

Tackling the procedure backlog

The Covid-19 pandemic has proven the ground for testing decentralised healthcare solutions.

AI

Cyclica’s AI-based drug discovery platform

MARKET

Technology innovation drives the intraocular lens market 

IVD companies seek M&As to avoid Covid cliff

The CGM-led diabetes market revolution post-Covid-19 outbreak

06/03/2021 08:46:29
  • Home | What’s next for wearables?
  • In this issue
  • Contents
  • Formacoat Company Insight
  • Formacoat
  • BioInteractions Company Insight
  • BioInteractions
  • Briefing
  • Industry news
  • Covid-19 executive briefing by GlobalData
  • The medical industry briefing
  • Repsol Company Insight
  • Repsol
  • Lenzing Plastics Company Insight
  • Lenzing Plastics
  • device25
  • Comment
  • IVD companies seek M&As to avoid Covid cliff
  • The CGM-led diabetes market revolution post-Covid-19 outbreak
  • Novel solutions to tackle backlog of delayed procedures
  • Sandvik Company Insight
  • Sandvik
  • Duke Empirical Company Insight
  • Duke Empirical
  • In Depth
  • How will Europe’s new device regulations affect medical software?
  • The next phase for medical wearables
  • How to future-proof the NHS supply chain
  • IUB Ballerine: an ergonomic approach to non-hormonal contraception
  • Creating connections with Within3
  • A womb with a view: the ethical dilemma of ectogenesis
  • Gee Plus
  • ElectroCraft Company Insight
  • ElectroCraft
  • GS Swiss
  • In Data
  • Deals analysis
  • The medical industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Coherent
  • On Line Controls
  • Biesterfeld
  • Events
  • Next Issue